BioCube Inc. | Balance Sheet

Fiscal year is February-January. All values USD Thousands.
2010
2011
2012
2013
2016
Cash & Short Term Investments
3.10
3.00
1.40
0.00
-
Other Current Assets
7.70
-
-
-
-
Total Current Assets
10.80
3.00
1.40
0.00
-
Total Investments and Advances
-
-
-
-
100.00
Long-Term Note Receivable
100.90
-
-
-
-
Intangible Assets
-
25.50
-
-
-
Other Assets
-
-
-
0.30
-
Total Assets
111.70
28.50
1.40
0.30
100.00
ST Debt & Current Portion LT Debt
12.20
34.50
34.50
839.40
1,519.30
Accounts Payable
-
162.70
97.60
92.70
-
Other Current Liabilities
26.00
371.90
554.70
257.10
898.40
Total Current Liabilities
38.10
569.10
686.70
1,189.10
2,417.80
Long-Term Debt
83.20
479.30
152.60
7.60
-
Other Liabilities
-
12.90
156.20
2.10
-
Total Liabilities
121.30
1,061.30
995.50
1,198.80
2,417.80
Common Equity (Total)
9.60
1,032.90
994.10
1,198.50
2,317.80
Total Shareholders' Equity
9.60
1,032.80
994.10
1,198.50
2,317.80
Total Equity
9.60
1,032.80
994.10
1,198.50
2,317.80
Liabilities & Shareholders' Equity
111.70
28.50
1.40
0.30
100.00
Preferred Stock (Carrying Value)
0.00
0.00
0.00
0.00
0.00

About BioCube

View Profile
Address
7320 North Dreamy Draw Drive
Phoenix Arizona 85020
United States
Employees -
Website -
Updated 07/08/2019
BioCube, Inc. operates as a biotechnology company which engages in identifying and facilitating the development of technologies, products, and services for medical and biological applications. Its products include cannasens delta9, american cannabis, and canadian cannabis. The company was founded on April 20, 2009 and is headquartered in Phoenix, AZ.